TEVA hit $40 after the FED, we should see $41 by end of the week
Sentiment: Strong Buy
Teva Pharmaceutical - Maxim Group initiated coverage of the pharmaceutical company with a "buy" rating and a price target of $56 a share. It will edge higher on a day to day basis
remaining above $40 will be the next challenge...